More than half of people with chronic hepatitis B have a form of the disease in which the immune system almost never achieves sustained control, despite many years of treatment. According to current knowledge, those affected ...
Mar 30, 2023
0
6
The overall responsiveness of patients with chronic liver disease (CLD) to COVID-19 vaccines has been shown to be decreased in patients with cirrhosis. A new prospective study in JHEP Reports shows that this lower response ...
Mar 2, 2023
0
3
In hepatic steatosis, hepatocytes "die," resulting in liver damage. Severe steatosis increases hepatocellular deaths, thus aggravating liver damage. The mechanism is unclear. Using mice, we show that mild steatosis causes ...
Feb 15, 2023
0
48
The hepatitis vaccines you receive as a child don't protect you from getting hepatitis C, a serious disease that can have fatal consequences including liver damage, cirrhosis and liver cancer.
Nov 22, 2022
0
5
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers ...
Nov 18, 2022
0
951
A 300-mg dose of bepirovirsen per week for 24 weeks results in sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in 9–10% of patients with chronic HBV infection, according to a study published ...
Nov 14, 2022
0
27
Around 1.5 million people worldwide become infected with the hepatitis B virus (HBV) every year. A research team led by the Paul-Ehrlich-Institut has identified a previously unknown pathway for the egress of hepatitis B virus ...
Nov 3, 2022
0
14
Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led ...
Nov 3, 2022
0
8
Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...
Sep 5, 2022
0
15
Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...
Jul 28, 2022
0
3
